Loading...
Novozymes A/S
NVZMF•PNK
Basic MaterialsChemicals - Specialty
$73.05
$0.81(1.12%)
Novozymes A/S (NVZMF) Financial Performance & Statements
Review Novozymes A/S’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-78.58%
↓ 78.58%
Operating Income Growth
-83.43%
↓ 83.43%
Net Income Growth
-89.89%
↓ 89.89%
Operating Cash Flow Growth
-75.44%
↓ 75.44%
Operating Margin
10.20%
↑ 10.20%
Gross Margin
43.95%
↑ 43.95%
Net Profit Margin
5.40%
↑ 5.40%
ROE
1.94%
↑ 1.94%
ROIC
12.30%
↑ 12.30%
Novozymes A/S (NVZMF) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Novozymes A/S stock.
| Metric | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $2.002B | $6.83B | $6.83B | $4.60B |
| Cost of Revenue | $959.30M | $3.97B | $3.97B | $2.12B |
| Gross Profit | $1.04B | $2.86B | $2.86B | $2.48B |
| Gross Profit Ratio | $0.52 | $0.42 | $0.42 | $0.54 |
| R&D Expenses | $218.70M | $725.39M | $725.43M | $524.00M |
| SG&A Expenses | $406.00M | $1.34B | $1.34B | $842.00M |
| Operating Expenses | $607.00M | $2.36B | $2.36B | $1.42B |
| Total Costs & Expenses | $1.57B | $6.33B | $6.33B | $3.53B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $30.00M |
| Depreciation & Amortization | $0.00 | $292.31M | $292.25M | $145.00M |
| EBITDA | $435.50M | $1.13B | $1.13B | $1.04B |
| EBITDA Ratio | $0.22 | $0.16 | $0.16 | $0.23 |
| Operating Income | $435.50M | $503.49M | $503.51M | $1.53B |
| Operating Income Ratio | $0.22 | $0.07 | $0.07 | $0.33 |
| Other Income/Expenses (Net) | -$108.40M | -$167.83M | -$167.84M | -$32.00M |
| Income Before Tax | $327.10M | $335.66M | $335.67M | $923.00M |
| Income Before Tax Ratio | $0.16 | $0.05 | $0.05 | $0.20 |
| Income Tax Expense | $85.20M | $97.34M | $97.35M | $228.00M |
| Net Income | $241.90M | $238.32M | $238.33M | $698.00M |
| Net Income Ratio | $0.12 | $0.03 | $0.03 | $0.15 |
| EPS | $0.53 | $0.86 | $0.86 | $2.52 |
| Diluted EPS | $0.53 | $0.86 | $0.86 | $2.51 |
| Weighted Avg Shares Outstanding | $456.42M | $277.90M | $277.90M | $278.03M |
| Weighted Avg Shares Outstanding (Diluted) | $456.42M | $277.90M | $277.90M | $278.40M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan